Serving Metropolitan Detroit Since 1944
Sorted by date Results 1 - 1 of 1
WASHINGTON - Today, the Biden-Harris Administration made a historic announcement, handing down a new rule that would allow Medicare and Medicaid programs to cover life-saving anti-obesity drugs such as Ozempic and Wegovy, from Novo Nordisk, and Mounjaro and Zepbound, from Eli Lilly. NAACP Director for the Center for Health Equity, Dr. Chris Pernell, released the following statement: "Today's announcement is a crucial first step in the fight to expand access to life-saving medications. The...